Vastagbélrák: vizsgálatok itt: Kína
616 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleFruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 84
- Run by
- Sun Yat-sen University
See details and how to joinNCT06441565 - No phaseTaking peopleShort-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial
- Where
- Xi'an
- Életkor
- 18 év and over
- People
- 360
- Run by
- Xiaoqin Luo
See details and how to joinNCT07087561 - 2. fázisTaking peopleLow-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
- Where
- Sanming, Shanghai
- Életkor
- 60 év and over
- People
- 50
- Run by
- Ruijin Hospital
See details and how to joinNCT07085169 - 2. fázisTaking peopleNeoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 143
- Run by
- Sun Yat-sen University
See details and how to joinNCT05571644 - 1. fázisTaking peopleSafety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 15
- Run by
- West China Hospital
See details and how to joinNCT07076823 - No phaseTaking peopleEffect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Multicenter Randomized Controlled Trial
- Where
- Yangzhou
- Életkor
- 18 év to 80 év
- People
- 300
- Run by
- Northern Jiangsu People's Hospital
See details and how to joinNCT07071987 - 3. fázisTaking peoplePlaned Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 186
- Run by
- West China Hospital
See details and how to joinNCT07070622 - 2. fázisNot yet taking people in KínaEfficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 44
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07070713 - No phaseTaking peopleDevelopment and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer:MetBio-CRC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 250
- Run by
- Shanghai Minimally Invasive Surgery Center
See details and how to joinNCT07068529 - No phaseNot yet taking people in KínaScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study Protocol
- Where
- Guangzhou
- Életkor
- 40 év to 75 év
- People
- 314
- Run by
- Sun Yat-sen University
See details and how to joinNCT06710860 - 2. fázisTaking peopleThalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 96
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT06279351 - 2. fázisNot yet taking people in KínaDual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 34
- Run by
- Sun Yat-sen University
See details and how to joinNCT07059338 - Korai 1. fázisTaking peopleA Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 20
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07050394 - 2. fázisTaking peopleLiposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 46
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07047560 - No phaseTaking peopleDevelopment and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy
- Where
- Beijing
- Életkor
- 40 év to 75 év
- People
- 150
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06957626 - 2. fázisTaking peopleClinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07044921 - No phaseNot yet taking people in KínaEvaluating AI and Human Expert Decisions in Colorectal Cancer
- Where
- Beijing
- People
- 1500
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07045207 - No phaseTaking peopleAn Exploratory Study on Gene Methylation Detection of Colorectal Cancer
- Where
- Hangzhou
- Életkor
- 40 év and over
- People
- 450
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT07033156 - No phaseTaking peopleThe Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
- Where
- Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Tianjin, Xi’an
- Életkor
- 18 év to 60 év
- People
- 1200
- Run by
- RenJi Hospital
See details and how to joinNCT06081647 - 1. fázisNot yet taking people in KínaA Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 66
- Run by
- Shanghai Bao Pharmaceuticals Co., Ltd.
See details and how to joinNCT07036185 - 2. fázisTaking peopleA Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
- Where
- Beijing, Shanghai
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06885385 - 1/2. fázisTaking peoplectDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 64
- Run by
- Sun Yat-sen University
See details and how to joinNCT07012954 - 1. fázisTaking peopleStudy on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 29
- Run by
- Ruijin Hospital
See details and how to joinNCT07035002 - 1. fázisNot yet taking people in KínaPD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
- Where
- Changchun
- Életkor
- 18 év to 75 év
- People
- 22
- Run by
- jiuwei cui
See details and how to joinNCT07031011 - 2. fázisTaking peopleVitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 25
- Run by
- Fudan University
See details and how to joinNCT05771181